743
Participants
Start Date
August 31, 2016
Primary Completion Date
August 31, 2019
Study Completion Date
December 31, 2019
MRD-directed therapy
The purpose of this study is to establish risk stratification based on cytogenetics at diagnosis and MRD analysis after induction chemotherapy and before consolidation chemotherapy to determine whether a MRD directed therapy for low and intermediate AML patients has positive results in terms of overall survival.
Nanfang Hospital, Southern Medical University, Guangzhou
Guangzhou First People's Hospital
OTHER
Zhujiang Hospital
OTHER
Peking University People's Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Nanfang Hospital, Southern Medical University
OTHER